Your browser doesn't support javascript.
loading
Early feeding practices in infants with phenylketonuria across Europe.
Pinto, A; Adams, S; Ahring, K; Allen, H; Almeida, M F; Garcia-Arenas, D; Arslan, N; Assoun, M; Atik Altinok, Y; Barrio-Carreras, D; Belanger Quintana, A; Bernabei, S M; Bontemps, C; Boyle, F; Bruni, G; Bueno-Delgado, M; Caine, G; Carvalho, R; Chrobot, A; Chyz, K; Cochrane, B; Correia, C; Corthouts, K; Daly, A; De Leo, S; Desloovere, A; De Meyer, A; De Theux, A; Didycz, B; Dijsselhof, M E; Dokoupil, K; Drabik, J; Dunlop, C; Eberle-Pelloth, W; Eftring, K; Ekengren, J; Errekalde, I; Evans, S; Foucart, A; Fokkema, L; François, L; French, M; Forssell, E; Gingell, C; Gonçalves, C; Gökmen Özel, H; Grimsley, A; Gugelmo, G; Gyüre, E; Heller, C.
Afiliación
  • Pinto A; Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Adams S; Royal Victoria Infirmary, Newcastle, UK.
  • Ahring K; Department of PKU, Kennedy Centre, Copenhagen University Hospital, Glostrup, Denmark.
  • Allen H; Sheffield Children's NHS Foundation Trust, UK.
  • Almeida MF; Centro de Genética Médica, Centro Hospitalar do Porto (CHP), Porto, Portugal.
  • Garcia-Arenas D; Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Institute of Biomedical Sciences, University of Porto-UMIB/ICBAS/UP, Porto, Portugal.
  • Arslan N; Centro de Referência na área de Doenças Hereditárias do Metabolismo, Centro Hospitalar do Porto - CHP, Porto, Portugal.
  • Assoun M; Congenital and Metabolic Disease Unit, Gastroenterology, Hepatology and Pediatric Nutrition Unit, Sant Joan de Déu Hospital, Barcelona, Spain.
  • Atik Altinok Y; Dokuz Eylul University Faculty of Medicine, Division of Pediatric Metabolism and Nutrition, Izmir, Turkey.
  • Barrio-Carreras D; Centre de référence des maladies héréditaires du métabolisme, Hôpital Necker enfants Malades, Paris, France.
  • Belanger Quintana A; Pediatric Metabolism Department, Ege University Medical Faculty, Izmir, Turkey.
  • Bernabei SM; Unidad de Enfermedades Mitocondriales-Metabolicas Hereditarias. Servicio de Pediatría, Hospital 12 de Octubre, Madrid, Spain.
  • Bontemps C; Unidad de Enfermedades Metabolicas, Servicio de Pediatria, Hospital Ramon y Cajal Madrid, Spain.
  • Boyle F; Children's Hospital Bambino Gesù, Division of Artificial Nutrition, Rome, Italy.
  • Bruni G; CHRU Clocheville Tours, France.
  • Bueno-Delgado M; National Centre for Inherited Metabolic Disorders, Temple Street Children's University Hospital, Ireland.
  • Caine G; Meyer Children's Hospital, Florence, Italy.
  • Carvalho R; Children's Hospital Virgen del Rocío, Seville, Spain.
  • Chrobot A; Mid Yorks NHS Trust, UK.
  • Chyz K; Hospital Divino Espírito Santo, Ponta Delgada, Portugal.
  • Cochrane B; Children Voievodship Hospital, Bydgoszcz, Poland.
  • Correia C; Institute of Mother and Child, Warsaw, Poland.
  • Corthouts K; Royal Hospital for Children, Glasgow, UK.
  • Daly A; CHLC- Hospital Dona Estefânia, Lisboa, Portugal.
  • De Leo S; University hospital Leuven, Belgium.
  • Desloovere A; Birmingham Women's and Children's Hospital, Birmingham, UK.
  • De Meyer A; Department of Human Neuroscience, Sapienza University of Rome - Policlinico Umberto I of Rome, Italy.
  • De Theux A; University hospital Ghent, Belgium.
  • Didycz B; Center of Metabolic Diseases, University Hospital, Antwerp, Belgium.
  • Dijsselhof ME; IPG (Institut de Pathologie et de Genetique), Charleroi, Belgium.
  • Dokoupil K; University Children's Hospital, Cracow, Poland.
  • Drabik J; AMC Amsterdam, Emma Children's Hospital, Netherlands.
  • Dunlop C; Dr. von Hauner Children's Hospital of the University of Munich, Germany.
  • Eberle-Pelloth W; University Clinical Center in Gdansk, Poland.
  • Eftring K; Royal Hospital for Children Edinburgh, UK.
  • Ekengren J; Universitäts-Kinderklinik Würzburg, Germany.
  • Errekalde I; Queen Silivia's Children's Hospital Gothenburg, Sweden.
  • Evans S; Queen Silivia's Children's Hospital Gothenburg, Sweden.
  • Foucart A; Hospital Universitario de Cruces, Vizcaya, Spain.
  • Fokkema L; Birmingham Women's and Children's Hospital, Birmingham, UK.
  • François L; Cliniques universitaires Saint-Luc, Belgium.
  • French M; UMC Utrecht, Wilhelmina Children's Hospital, Netherlands.
  • Forssell E; Hôpital Universitaire Robert-Debré, Centre de référence des maladies héréditaires du métabolisme, Paris, France.
  • Gingell C; University Hospitals of Leicester NHS Trust, UK.
  • Gonçalves C; Karolinska University Hospital, Stockholm, Sweden.
  • Gökmen Özel H; Nottingham Children's Hospital, UK.
  • Grimsley A; Hospital Central do Funchal, Portugal.
  • Gugelmo G; Hacettepe University, Ihsan Dogramaci Children's Hospital, Turkey.
  • Gyüre E; Royal Belfast Hospital for Sick Children, Northern Ireland, UK.
  • Heller C; Department of Pediatrics, Inherited Metabolic Diseases Unit, University Hospital of Verona, Italy.
Mol Genet Metab Rep ; 16: 82-89, 2018 Sep.
Article en En | MEDLINE | ID: mdl-30101073
BACKGROUND: In infants with phenylketonuria (PKU), dietary management is based on lowering and titrating phenylalanine (Phe) intake from breast milk or standard infant formula in combination with a Phe-free infant formula in order to maintain blood Phe levels within target range. Professionals use different methods to feed infants with PKU and our survey aimed to document practices across Europe. METHODS: We sent a cross sectional, survey monkey® questionnaire to European health professionals working in IMD. It contained 31 open and multiple-choice questions. The results were analysed according to different geographical regions. RESULTS: Ninety-five centres from 21 countries responded. Over 60% of centres commenced diet in infants by age 10 days, with 58% of centres implementing newborn screening by day 3 post birth. At diagnosis, infant hospital admission occurred in 61% of metabolic centres, mainly in Eastern, Western and Southern Europe. Breastfeeding fell sharply following diagnosis with only 30% of women still breast feeding at 6 months.53% of centres gave pre-measured Phe-free infant formula before each breast feed and 23% alternated breast feeds with Phe-free infant formula. With standard infant formula feeds, measured amounts were followed by Phe-free infant formula to satiety in 37% of centres (n = 35/95), whereas 44% (n = 42/95) advised mixing both formulas together. Weaning commenced between 17 and 26 weeks in 85% centres, ≥26 weeks in 12% and < 17 weeks in 3%. DISCUSSION: This is the largest European survey completed on PKU infant feeding practices. It is evident that practices varied widely across Europe, and the practicalities of infant feeding in PKU received little focus in the PKU European Guidelines (2017). There are few reports comparing different feeding techniques with blood Phe control, Phe fluctuations and growth. Controlled prospective studies are necessary to assess how different infant feeding practices may influence longer term feeding development.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Qualitative_research Idioma: En Revista: Mol Genet Metab Rep Año: 2018 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Qualitative_research Idioma: En Revista: Mol Genet Metab Rep Año: 2018 Tipo del documento: Article